0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biolayer Interferometry (BLI) Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-32S17377
Home | Market Reports | Science
Global Biolayer Interferometry BLI Market Research Report 2024
BUY CHAPTERS

Global Biolayer Interferometry (BLI) Market Research Report 2025

Code: QYRE-Auto-32S17377
Report
March 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biolayer Interferometry (BLI) Market Size

The global market for Biolayer Interferometry (BLI) was valued at US$ 370 million in the year 2024 and is projected to reach a revised size of US$ 668 million by 2031, growing at a CAGR of 9.4% during the forecast period.

Biolayer Interferometry (BLI) Market

Biolayer Interferometry (BLI) Market

Biolayer Interferometry (BLI) is a label-free optical technique for measuring biomolecular interactions in real-time. It analyzes the interference pattern of white light reflected from an immobilized protein layer on the biosensor tip and an internal reference layer. Only molecules binding to or dissociating from the biosensor can shift the interference pattern, making BLI unique and ideal for protein binding, quantitation, affinity, and kinetics in crude samples. Bio-Layer Interferometry measures biomolecular interactions by analyzing interference patterns of white light reflected from the surface of a biosensor tip. In BLI experiment, one molecule is immobilized to a biosensor and binding to a second molecule is measured. The molecules that bind or dissociate themselves from the biosensor causes a shift in the interference pattern that is measured in real-time. The unbound molecules, variations in the refractive index of the surrounding medium or flow rate, however, do not affect the interference. This unique feature of BLI technology therefore allows measuring crude samples to determine the kinetics and affinity of molecular interactions. Anotheradvantage of BLI is that the number of sensors can be scaled up easily without making the system more error-prone or complex. Theoretically, there is no need to regenerate single sensors, because immobilizing an equal amount of ligand on additional sensors can easily create duplicates of the surface.
The Biolayer Interferometry (BLI) market has been expanding rapidly due to its increasing use in a wide range of applications such as drug discovery, biotechnology, diagnostics, and life sciences research. BLI is a powerful, label-free, and real-time optical biosensing technique that is widely used for studying molecular interactions. Here are the most prominent market trends for BLI:
BLI is becoming an essential tool in drug discovery and biopharmaceutical development. The technique is crucial for assessing the interactions of small molecules, antibodies, peptides, and other therapeutics with biological targets. BLI is particularly useful in the screening of drug candidates, kinetic analysis, and the characterization of biologics like monoclonal antibodies and biosimilars.
With increased emphasis on biologics, biomolecular interactions, and antibody-drug conjugates (ADCs), the demand for BLI instruments is surging in pharmaceutical research labs, contract research organizations (CROs), and biotechnology companies.
One of the key advantages of BLI is its ability to monitor biomolecular interactions in real-time without the need for labels like fluorescence or radioactivity. This is especially important for applications in kinetic studies, where changes in molecular binding or dissociation are observed in real time. The technology’s label-free nature also makes it a more cost-effective and sustainable option compared to traditional assays.
Real-time monitoring allows for high-throughput analysis, which is essential for large-scale drug screening campaigns and biomarker discovery.
The BLI market is benefiting from its integration with high-throughput screening (HTS) platforms. The combination of label-free detection and the ability to screen large numbers of samples in a short time is making BLI a popular choice in drug development and compound screening. This integration is especially useful for accelerating the early stages of drug discovery.
Many manufacturers are developing BLI systems that can be easily integrated into existing HTS workflows, improving efficiency and throughput while providing high-quality interaction data.
This report aims to provide a comprehensive presentation of the global market for Biolayer Interferometry (BLI), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biolayer Interferometry (BLI).
The Biolayer Interferometry (BLI) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biolayer Interferometry (BLI) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biolayer Interferometry (BLI) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Biolayer Interferometry (BLI) Market Report

Report Metric Details
Report Name Biolayer Interferometry (BLI) Market
Accounted market size in year US$ 370 million
Forecasted market size in 2031 US$ 668 million
CAGR 9.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Ichor Life Sciences, Inc, Creative BioMart, GenScript, ROCKLAND IMMUNOCHEMICALS, INC, BPS Bioscience, Inc, Creative Proteomics, Creative Biostructure, Profacgen, Creative Biolabs, Biocult, KMD Bioscience Co., Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Biolayer Interferometry (BLI) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Biolayer Interferometry (BLI) Market growing?

Ans: The Biolayer Interferometry (BLI) Market witnessing a CAGR of 9.4% during the forecast period 2025-2031.

What is the Biolayer Interferometry (BLI) Market size in 2031?

Ans: The Biolayer Interferometry (BLI) Market size in 2031 will be US$ 668 million.

Who are the main players in the Biolayer Interferometry (BLI) Market report?

Ans: The main players in the Biolayer Interferometry (BLI) Market are Ichor Life Sciences, Inc, Creative BioMart, GenScript, ROCKLAND IMMUNOCHEMICALS, INC, BPS Bioscience, Inc, Creative Proteomics, Creative Biostructure, Profacgen, Creative Biolabs, Biocult, KMD Bioscience Co., Ltd

What are the Application segmentation covered in the Biolayer Interferometry (BLI) Market report?

Ans: The Applications covered in the Biolayer Interferometry (BLI) Market report are Pharmaceutical Industry, Diagnostics, Biotechnology, Scientific Research, Others

What are the Type segmentation covered in the Biolayer Interferometry (BLI) Market report?

Ans: The Types covered in the Biolayer Interferometry (BLI) Market report are Affinity and Kinetic Analysis, Drug and Antibody Screening, Drug and Antibody Discovery, Protein Quantification, Others

Recommended Reports

Optical Interferometry

Bio Sensors Market

Biomedical Optics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biolayer Interferometry (BLI) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Affinity and Kinetic Analysis
1.2.3 Drug and Antibody Screening
1.2.4 Drug and Antibody Discovery
1.2.5 Protein Quantification
1.2.6 Others
1.3 Market by Application
1.3.1 Global Biolayer Interferometry (BLI) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Industry
1.3.3 Diagnostics
1.3.4 Biotechnology
1.3.5 Scientific Research
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biolayer Interferometry (BLI) Market Perspective (2020-2031)
2.2 Global Biolayer Interferometry (BLI) Growth Trends by Region
2.2.1 Global Biolayer Interferometry (BLI) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biolayer Interferometry (BLI) Historic Market Size by Region (2020-2025)
2.2.3 Biolayer Interferometry (BLI) Forecasted Market Size by Region (2026-2031)
2.3 Biolayer Interferometry (BLI) Market Dynamics
2.3.1 Biolayer Interferometry (BLI) Industry Trends
2.3.2 Biolayer Interferometry (BLI) Market Drivers
2.3.3 Biolayer Interferometry (BLI) Market Challenges
2.3.4 Biolayer Interferometry (BLI) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biolayer Interferometry (BLI) Players by Revenue
3.1.1 Global Top Biolayer Interferometry (BLI) Players by Revenue (2020-2025)
3.1.2 Global Biolayer Interferometry (BLI) Revenue Market Share by Players (2020-2025)
3.2 Global Top Biolayer Interferometry (BLI) Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biolayer Interferometry (BLI) Revenue
3.4 Global Biolayer Interferometry (BLI) Market Concentration Ratio
3.4.1 Global Biolayer Interferometry (BLI) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biolayer Interferometry (BLI) Revenue in 2024
3.5 Global Key Players of Biolayer Interferometry (BLI) Head office and Area Served
3.6 Global Key Players of Biolayer Interferometry (BLI), Product and Application
3.7 Global Key Players of Biolayer Interferometry (BLI), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biolayer Interferometry (BLI) Breakdown Data by Type
4.1 Global Biolayer Interferometry (BLI) Historic Market Size by Type (2020-2025)
4.2 Global Biolayer Interferometry (BLI) Forecasted Market Size by Type (2026-2031)
5 Biolayer Interferometry (BLI) Breakdown Data by Application
5.1 Global Biolayer Interferometry (BLI) Historic Market Size by Application (2020-2025)
5.2 Global Biolayer Interferometry (BLI) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biolayer Interferometry (BLI) Market Size (2020-2031)
6.2 North America Biolayer Interferometry (BLI) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biolayer Interferometry (BLI) Market Size by Country (2020-2025)
6.4 North America Biolayer Interferometry (BLI) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biolayer Interferometry (BLI) Market Size (2020-2031)
7.2 Europe Biolayer Interferometry (BLI) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biolayer Interferometry (BLI) Market Size by Country (2020-2025)
7.4 Europe Biolayer Interferometry (BLI) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biolayer Interferometry (BLI) Market Size (2020-2031)
8.2 Asia-Pacific Biolayer Interferometry (BLI) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biolayer Interferometry (BLI) Market Size by Region (2020-2025)
8.4 Asia-Pacific Biolayer Interferometry (BLI) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biolayer Interferometry (BLI) Market Size (2020-2031)
9.2 Latin America Biolayer Interferometry (BLI) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biolayer Interferometry (BLI) Market Size by Country (2020-2025)
9.4 Latin America Biolayer Interferometry (BLI) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biolayer Interferometry (BLI) Market Size (2020-2031)
10.2 Middle East & Africa Biolayer Interferometry (BLI) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biolayer Interferometry (BLI) Market Size by Country (2020-2025)
10.4 Middle East & Africa Biolayer Interferometry (BLI) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ichor Life Sciences, Inc
11.1.1 Ichor Life Sciences, Inc Company Details
11.1.2 Ichor Life Sciences, Inc Business Overview
11.1.3 Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Introduction
11.1.4 Ichor Life Sciences, Inc Revenue in Biolayer Interferometry (BLI) Business (2020-2025)
11.1.5 Ichor Life Sciences, Inc Recent Development
11.2 Creative BioMart
11.2.1 Creative BioMart Company Details
11.2.2 Creative BioMart Business Overview
11.2.3 Creative BioMart Biolayer Interferometry (BLI) Introduction
11.2.4 Creative BioMart Revenue in Biolayer Interferometry (BLI) Business (2020-2025)
11.2.5 Creative BioMart Recent Development
11.3 GenScript
11.3.1 GenScript Company Details
11.3.2 GenScript Business Overview
11.3.3 GenScript Biolayer Interferometry (BLI) Introduction
11.3.4 GenScript Revenue in Biolayer Interferometry (BLI) Business (2020-2025)
11.3.5 GenScript Recent Development
11.4 ROCKLAND IMMUNOCHEMICALS, INC
11.4.1 ROCKLAND IMMUNOCHEMICALS, INC Company Details
11.4.2 ROCKLAND IMMUNOCHEMICALS, INC Business Overview
11.4.3 ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Introduction
11.4.4 ROCKLAND IMMUNOCHEMICALS, INC Revenue in Biolayer Interferometry (BLI) Business (2020-2025)
11.4.5 ROCKLAND IMMUNOCHEMICALS, INC Recent Development
11.5 BPS Bioscience, Inc
11.5.1 BPS Bioscience, Inc Company Details
11.5.2 BPS Bioscience, Inc Business Overview
11.5.3 BPS Bioscience, Inc Biolayer Interferometry (BLI) Introduction
11.5.4 BPS Bioscience, Inc Revenue in Biolayer Interferometry (BLI) Business (2020-2025)
11.5.5 BPS Bioscience, Inc Recent Development
11.6 Creative Proteomics
11.6.1 Creative Proteomics Company Details
11.6.2 Creative Proteomics Business Overview
11.6.3 Creative Proteomics Biolayer Interferometry (BLI) Introduction
11.6.4 Creative Proteomics Revenue in Biolayer Interferometry (BLI) Business (2020-2025)
11.6.5 Creative Proteomics Recent Development
11.7 Creative Biostructure
11.7.1 Creative Biostructure Company Details
11.7.2 Creative Biostructure Business Overview
11.7.3 Creative Biostructure Biolayer Interferometry (BLI) Introduction
11.7.4 Creative Biostructure Revenue in Biolayer Interferometry (BLI) Business (2020-2025)
11.7.5 Creative Biostructure Recent Development
11.8 Profacgen
11.8.1 Profacgen Company Details
11.8.2 Profacgen Business Overview
11.8.3 Profacgen Biolayer Interferometry (BLI) Introduction
11.8.4 Profacgen Revenue in Biolayer Interferometry (BLI) Business (2020-2025)
11.8.5 Profacgen Recent Development
11.9 Creative Biolabs
11.9.1 Creative Biolabs Company Details
11.9.2 Creative Biolabs Business Overview
11.9.3 Creative Biolabs Biolayer Interferometry (BLI) Introduction
11.9.4 Creative Biolabs Revenue in Biolayer Interferometry (BLI) Business (2020-2025)
11.9.5 Creative Biolabs Recent Development
11.10 Biocult
11.10.1 Biocult Company Details
11.10.2 Biocult Business Overview
11.10.3 Biocult Biolayer Interferometry (BLI) Introduction
11.10.4 Biocult Revenue in Biolayer Interferometry (BLI) Business (2020-2025)
11.10.5 Biocult Recent Development
11.11 KMD Bioscience Co., Ltd
11.11.1 KMD Bioscience Co., Ltd Company Details
11.11.2 KMD Bioscience Co., Ltd Business Overview
11.11.3 KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Introduction
11.11.4 KMD Bioscience Co., Ltd Revenue in Biolayer Interferometry (BLI) Business (2020-2025)
11.11.5 KMD Bioscience Co., Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Biolayer Interferometry (BLI) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Affinity and Kinetic Analysis
 Table 3. Key Players of Drug and Antibody Screening
 Table 4. Key Players of Drug and Antibody Discovery
 Table 5. Key Players of Protein Quantification
 Table 6. Key Players of Others
 Table 7. Global Biolayer Interferometry (BLI) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Biolayer Interferometry (BLI) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Biolayer Interferometry (BLI) Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Biolayer Interferometry (BLI) Market Share by Region (2020-2025)
 Table 11. Global Biolayer Interferometry (BLI) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Biolayer Interferometry (BLI) Market Share by Region (2026-2031)
 Table 13. Biolayer Interferometry (BLI) Market Trends
 Table 14. Biolayer Interferometry (BLI) Market Drivers
 Table 15. Biolayer Interferometry (BLI) Market Challenges
 Table 16. Biolayer Interferometry (BLI) Market Restraints
 Table 17. Global Biolayer Interferometry (BLI) Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Biolayer Interferometry (BLI) Market Share by Players (2020-2025)
 Table 19. Global Top Biolayer Interferometry (BLI) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biolayer Interferometry (BLI) as of 2024)
 Table 20. Ranking of Global Top Biolayer Interferometry (BLI) Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Biolayer Interferometry (BLI) Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Biolayer Interferometry (BLI), Headquarters and Area Served
 Table 23. Global Key Players of Biolayer Interferometry (BLI), Product and Application
 Table 24. Global Key Players of Biolayer Interferometry (BLI), Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Biolayer Interferometry (BLI) Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Biolayer Interferometry (BLI) Revenue Market Share by Type (2020-2025)
 Table 28. Global Biolayer Interferometry (BLI) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Biolayer Interferometry (BLI) Revenue Market Share by Type (2026-2031)
 Table 30. Global Biolayer Interferometry (BLI) Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Biolayer Interferometry (BLI) Revenue Market Share by Application (2020-2025)
 Table 32. Global Biolayer Interferometry (BLI) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Biolayer Interferometry (BLI) Revenue Market Share by Application (2026-2031)
 Table 34. North America Biolayer Interferometry (BLI) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Biolayer Interferometry (BLI) Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Biolayer Interferometry (BLI) Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Biolayer Interferometry (BLI) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Biolayer Interferometry (BLI) Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Biolayer Interferometry (BLI) Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Biolayer Interferometry (BLI) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Biolayer Interferometry (BLI) Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Biolayer Interferometry (BLI) Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Biolayer Interferometry (BLI) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Biolayer Interferometry (BLI) Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Biolayer Interferometry (BLI) Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Biolayer Interferometry (BLI) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Biolayer Interferometry (BLI) Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Biolayer Interferometry (BLI) Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Ichor Life Sciences, Inc Company Details
 Table 50. Ichor Life Sciences, Inc Business Overview
 Table 51. Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Product
 Table 52. Ichor Life Sciences, Inc Revenue in Biolayer Interferometry (BLI) Business (2020-2025) & (US$ Million)
 Table 53. Ichor Life Sciences, Inc Recent Development
 Table 54. Creative BioMart Company Details
 Table 55. Creative BioMart Business Overview
 Table 56. Creative BioMart Biolayer Interferometry (BLI) Product
 Table 57. Creative BioMart Revenue in Biolayer Interferometry (BLI) Business (2020-2025) & (US$ Million)
 Table 58. Creative BioMart Recent Development
 Table 59. GenScript Company Details
 Table 60. GenScript Business Overview
 Table 61. GenScript Biolayer Interferometry (BLI) Product
 Table 62. GenScript Revenue in Biolayer Interferometry (BLI) Business (2020-2025) & (US$ Million)
 Table 63. GenScript Recent Development
 Table 64. ROCKLAND IMMUNOCHEMICALS, INC Company Details
 Table 65. ROCKLAND IMMUNOCHEMICALS, INC Business Overview
 Table 66. ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Product
 Table 67. ROCKLAND IMMUNOCHEMICALS, INC Revenue in Biolayer Interferometry (BLI) Business (2020-2025) & (US$ Million)
 Table 68. ROCKLAND IMMUNOCHEMICALS, INC Recent Development
 Table 69. BPS Bioscience, Inc Company Details
 Table 70. BPS Bioscience, Inc Business Overview
 Table 71. BPS Bioscience, Inc Biolayer Interferometry (BLI) Product
 Table 72. BPS Bioscience, Inc Revenue in Biolayer Interferometry (BLI) Business (2020-2025) & (US$ Million)
 Table 73. BPS Bioscience, Inc Recent Development
 Table 74. Creative Proteomics Company Details
 Table 75. Creative Proteomics Business Overview
 Table 76. Creative Proteomics Biolayer Interferometry (BLI) Product
 Table 77. Creative Proteomics Revenue in Biolayer Interferometry (BLI) Business (2020-2025) & (US$ Million)
 Table 78. Creative Proteomics Recent Development
 Table 79. Creative Biostructure Company Details
 Table 80. Creative Biostructure Business Overview
 Table 81. Creative Biostructure Biolayer Interferometry (BLI) Product
 Table 82. Creative Biostructure Revenue in Biolayer Interferometry (BLI) Business (2020-2025) & (US$ Million)
 Table 83. Creative Biostructure Recent Development
 Table 84. Profacgen Company Details
 Table 85. Profacgen Business Overview
 Table 86. Profacgen Biolayer Interferometry (BLI) Product
 Table 87. Profacgen Revenue in Biolayer Interferometry (BLI) Business (2020-2025) & (US$ Million)
 Table 88. Profacgen Recent Development
 Table 89. Creative Biolabs Company Details
 Table 90. Creative Biolabs Business Overview
 Table 91. Creative Biolabs Biolayer Interferometry (BLI) Product
 Table 92. Creative Biolabs Revenue in Biolayer Interferometry (BLI) Business (2020-2025) & (US$ Million)
 Table 93. Creative Biolabs Recent Development
 Table 94. Biocult Company Details
 Table 95. Biocult Business Overview
 Table 96. Biocult Biolayer Interferometry (BLI) Product
 Table 97. Biocult Revenue in Biolayer Interferometry (BLI) Business (2020-2025) & (US$ Million)
 Table 98. Biocult Recent Development
 Table 99. KMD Bioscience Co., Ltd Company Details
 Table 100. KMD Bioscience Co., Ltd Business Overview
 Table 101. KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Product
 Table 102. KMD Bioscience Co., Ltd Revenue in Biolayer Interferometry (BLI) Business (2020-2025) & (US$ Million)
 Table 103. KMD Bioscience Co., Ltd Recent Development
 Table 104. Research Programs/Design for This Report
 Table 105. Key Data Information from Secondary Sources
 Table 106. Key Data Information from Primary Sources
 Table 107. Authors List of This Report


List of Figures
 Figure 1. Biolayer Interferometry (BLI) Picture
 Figure 2. Global Biolayer Interferometry (BLI) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biolayer Interferometry (BLI) Market Share by Type: 2024 VS 2031
 Figure 4. Affinity and Kinetic Analysis Features
 Figure 5. Drug and Antibody Screening Features
 Figure 6. Drug and Antibody Discovery Features
 Figure 7. Protein Quantification Features
 Figure 8. Others Features
 Figure 9. Global Biolayer Interferometry (BLI) Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Biolayer Interferometry (BLI) Market Share by Application: 2024 VS 2031
 Figure 11. Pharmaceutical Industry Case Studies
 Figure 12. Diagnostics Case Studies
 Figure 13. Biotechnology Case Studies
 Figure 14. Scientific Research Case Studies
 Figure 15. Others Case Studies
 Figure 16. Biolayer Interferometry (BLI) Report Years Considered
 Figure 17. Global Biolayer Interferometry (BLI) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Biolayer Interferometry (BLI) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Biolayer Interferometry (BLI) Market Share by Region: 2024 VS 2031
 Figure 20. Global Biolayer Interferometry (BLI) Market Share by Players in 2024
 Figure 21. Global Biolayer Interferometry (BLI) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 22. The Top 10 and 5 Players Market Share by Biolayer Interferometry (BLI) Revenue in 2024
 Figure 23. North America Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Biolayer Interferometry (BLI) Market Share by Country (2020-2031)
 Figure 25. United States Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Biolayer Interferometry (BLI) Market Share by Country (2020-2031)
 Figure 29. Germany Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Biolayer Interferometry (BLI) Market Share by Region (2020-2031)
 Figure 37. China Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Biolayer Interferometry (BLI) Market Share by Country (2020-2031)
 Figure 45. Mexico Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Biolayer Interferometry (BLI) Market Share by Country (2020-2031)
 Figure 49. Turkey Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Biolayer Interferometry (BLI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Ichor Life Sciences, Inc Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2020-2025)
 Figure 53. Creative BioMart Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2020-2025)
 Figure 54. GenScript Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2020-2025)
 Figure 55. ROCKLAND IMMUNOCHEMICALS, INC Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2020-2025)
 Figure 56. BPS Bioscience, Inc Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2020-2025)
 Figure 57. Creative Proteomics Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2020-2025)
 Figure 58. Creative Biostructure Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2020-2025)
 Figure 59. Profacgen Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2020-2025)
 Figure 60. Creative Biolabs Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2020-2025)
 Figure 61. Biocult Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2020-2025)
 Figure 62. KMD Bioscience Co., Ltd Revenue Growth Rate in Biolayer Interferometry (BLI) Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Ecology Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29H6022
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Robotics Paint Booth Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3R7922
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart